PT  - JOURNAL ARTICLE
AU  - Chatio, Samuel Tamti
AU  - Ganle, John Kuumuori
AU  - Adongo, Philip Baba
AU  - Beisel, Ulrike
TI  - Factors affecting trust in clinical trials conduct: Views of stakeholders from a qualitative study in Ghana
AID  - 10.1101/2022.10.05.22280221
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.10.05.22280221
4099  - http://medrxiv.org/content/early/2022/10/07/2022.10.05.22280221.short
4100  - http://medrxiv.org/content/early/2022/10/07/2022.10.05.22280221.full
AB  - Introduction Globally, there are signs of declining public trust in science, especially in biomedical research. In Ghana, there are equally signs of public distrust in the conduct of biomedical research in Ghana. Typical examples are the unsuccessful conduct of the Ebola vaccine trial and the initial refusal of parents to allow their children to receive the recently piloted malaria vaccine in Ghana. Therefore, this study explored stakeholders’ views on factors affecting trust in clinical trials conduct in Ghana.Methods This was a cross-sectional exploratory study using qualitative research approach. Forty-eight in-depth interviews and Key informant interviews were conducted with stakeholders. Purposive sampling technique was used to select participants. All the interviews were recorded, transcribed and coded into main and sub-themes using QSR Nvivo 12 software to aid thematic analysis.Results Overall, participants saw the need for the conduct of clinical trials in Ghana because clinical trial studies enable scientists to come out with effective medicines for the management of diseases. Pre-implementation factors such as inadequate stakeholder engagement, rumours and negative influence affected trust. Implementation factors such as perceived risks about clinical trials medicines, apprehensions on drawing and use of blood samples, poor informed consent administration and perceived no illness all negatively affected trust in clinical trials conduct.Conclusion Trust is a fundamental factor affecting a successful conduct of clinical trials. Thus, there is need for collective efforts by all stakeholders including research institutions and clinical trial regulatory bodies to take the issue of trust in clinical trials conduct seriously.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe bigger study was founded by German Research Foundation. The funders did not play any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was reviewed and approved by the Ghana Health Service Ethics Review Committee (GHS-ERC007/08/18).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPortion of the data was used in this study. The data will be made available upon request by the journal